Why patients are searching for MEDVi alternatives

MEDVi grew from zero to over 500,000 patients in under two years. That growth came with serious problems that became public in 2025 and 2026. Here are the documented reasons patients are now actively looking for alternatives.

1.6M

Patient data breach

OpenLoop Health — MEDVi's clinical partner — suffered a breach in January 2026 exposing 1.6 million patient records including medical information.

FDA

Warning letter issued

The FDA issued MEDVi a warning letter in February 2026 for misleading advertising claims about compounded GLP-1 medications.

RICO

Federal lawsuit

A federal class action complaint filed in November 2025 alleges MEDVi sold ineffective compounded oral tirzepatide as "modern-day snake oil."

F

BBB rating

MEDVi has an F rating from the Better Business Bureau with 361 filed complaints — primarily for billing issues and cancellation difficulty.

0

Spanish support

MEDVi is English-only. 65 million US Hispanic adults have no bilingual GLP-1 telehealth option — until now.

AI

Fake photos

Futurism reported that MEDVi used AI-generated deepfake before/after photos in their marketing materials.

What to look for in a MEDVi alternative

Not all GLP-1 telehealth platforms are the same. When evaluating a MEDVi alternative, these are the factors that matter most:

The top MEDVi alternatives in 2026

Hims & Hers
Established brand — but also breached
The largest telehealth platform in the US ($2.35B revenue 2025). Known brand recognition. However: also confirmed a data breach in April 2026, received an FDA warning letter in September 2025, and has no Spanish support.
Large, established brand
Broad product range
Wegovy Pill available from $149/mo
Confirmed data breach April 2, 2026
FDA warning letter September 2025
15–20 marketing emails per day (reported)
No refund policy, no Spanish support
$149
from/mo
semaglutide
Ro
Premium option — expensive and inflexible
BBB A+ rated and NABP accredited. Best insurance navigation support. However: charges $145/month membership fee before any medication, making all-in cost $474–$544/month. No phone support, no Spanish, and a notorious $45 bait-and-switch intro offer.
BBB A+ rating
NABP accredited
Best for insurance coverage navigation
$145/mo membership + medication = $474+ all-in
$45 intro bait-and-switch reported
No phone support
No Spanish support
$474+
true all-in
per month

The gap none of them fill — except REMEVi

Here is the fact that no comparison article mentions: every single MEDVi alternative on every existing list — Hims, Ro, LifeMD, Henry Meds — is English only.

There are 65 million Spanish-speaking adults in the United States. The adult obesity rate among Hispanic Americans is approximately 45.6% — among the highest of any demographic group. Less than 10% have ever used a prescription weight loss medication. The reason is not lack of interest. It is lack of access to healthcare that speaks their language.

REMEVi exists to close that gap. We are the only GLP-1 telehealth platform that a Spanish-speaking patient can use entirely in their own language — from the first intake question to the last support message.

Start in English

Bilingual care. Transparent pricing. No data breaches. Starting $169/mo.

Get started →

Empieza en español

La primera plataforma GLP-1 completamente bilingüe. Desde $169/mes.

Empieza aquí →

How to switch from MEDVi to REMEVi

Switching GLP-1 platforms is straightforward. Here is how to do it without interrupting your treatment:

  1. Don't stop your medication abruptly. Time your switch so your last MEDVi shipment overlaps with your REMEVi approval window.
  2. Cancel MEDVi before your next billing date. Based on customer reviews, the most reliable cancellation method is MEDVi's in-portal chat support. Email also works but takes longer. Keep a screenshot of your cancellation confirmation.
  3. Start your REMEVi intake. During the intake questionnaire, note your current GLP-1 medication and dosage. Our clinical partner's physicians will review this and maintain your dosing continuity where appropriate.
  4. Choose your language preference. At intake, select English or Spanish. Every communication from that point will be in your chosen language.
  5. Expect approval within 24–48 hours. After your intake is reviewed by a licensed physician, your prescription is sent to our pharmacy partner for fulfillment.

Frequently asked questions about MEDVi alternatives

REMEVi is the best MEDVi alternative for most patients in 2026, particularly those who want bilingual Spanish support, a clean data security record, or who have experienced MEDVi's billing and cancellation issues. For patients specifically seeking insurance coverage navigation, Ro is the strongest option despite its higher all-in cost. For patients who want the largest established brand, Hims & Hers is available — but note they also had a data breach in April 2026.
Yes — REMEVi is the first and only GLP-1 telehealth platform offering full bilingual English/Spanish service in the United States. Every other platform (MEDVi, Hims, Ro, LifeMD) is English-only. REMEVi offers intake, support, medication instructions, and care coordination entirely in Spanish. Sí — REMEVi es la única plataforma de telesalud GLP-1 que ofrece servicio bilingüe completo en inglés y español en los Estados Unidos.
The main documented reasons: (1) January 2026 — OpenLoop Health, MEDVi's clinical partner, suffered a 1.6 million patient data breach. (2) February 2026 — MEDVi received an FDA warning letter for misleading advertising about compounded GLP-1s. (3) November 2025 — A federal RICO class action lawsuit was filed against MEDVi. (4) Ongoing — MEDVi has an F BBB rating with 361 complaints, primarily for billing issues, unexpected charges after cancellation, and unresponsive support.
Yes, slightly. REMEVi GLP-1 semaglutide starts at $169/month intro (vs MEDVi's $179) and $279/month ongoing (vs MEDVi's $299). Both are all-inclusive with no separate membership fees. REMEVi also includes bilingual support at no extra cost — something MEDVi does not offer in any form.
REMEVi. MEDVi has had "Women's Health — Coming Soon" on their website for over a year. REMEVi launched with a complete women's health program including GLP-1 weight loss, hormone replacement therapy (HRT), hair care, and skin care — all in English and Spanish. Hims & Hers has their Hers brand but it is frequently criticized for being Hims rebranded rather than a genuine women-first platform.

The MEDVi alternative you've been looking for.

Bilingual. Trustworthy. All-inclusive from $169/month. No data breaches. No FDA warnings. Real humans.

Start with REMEVi today →

Disclaimer: This guide is based on publicly available information, BBB records, FDA public filings, court documents, and verified customer reviews as of April 2026. REMEVi is not affiliated with MEDVi, Hims & Hers, Ro, or their partners. All pricing and comparative claims should be independently verified. This content is for informational purposes only and does not constitute medical advice. GLP-1 medications require evaluation by a licensed healthcare provider.